IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition

Bozzo, Caterina Prelli; Nchioua, Rayhane; Volcic, Meta; Krüger, Jana; Heller, Sandra; Stürzel, Christina M.; Kmiec, Dorota; Conzelmann, Carina; Müller, Janis; Zech, Fabian; Schütz, Desiree; Koepke, Lennart; Braun, Elisabeth; Groß, Rüdiger; Wettstein, Lukas; Weil, Tatjana; Weiß, Johanna; Sauter, Daniel; Münch, Jan; Diofano, Federica; Goffinet, Christine; Catanese, Alberto; Schön, Michael; Böckers, Tobias; Stenger, Steffen; Sato, Kei; Just, Steffen; Kleger, Alexander; Sparrer, Konstantin M.J.; Kirchhoff, Frank

Interferon-induced transmembrane proteins (IFITMs 1, 2 and 3) are thought to restrict numerous viral pathogens including severe acute respiratory syndrome coronaviruses (SARS-CoVs). However, most evidence comes from single-round pseudovirus infection studies of cells that overexpress IFITMs. Here, we verified that artificial overexpression of IFITMs blocks SARS-CoV-2 infection. Strikingly, however, endogenous IFITM expression was essential for efficient infection of genuine SARS-CoV-2 in human lung cells. Our results indicate that the SARS-CoV-2 Spike protein interacts with IFITMs and hijacks them for efficient viral entry. IFITM proteins were expressed and further induced by interferons in human lung, gut, heart and brain cells. Intriguingly, IFITM-derived peptides and targeting antibodies inhibited SARS-CoV-2 entry and replication in human lung cells, cardiomyocytes and gut organoids. Our results show that IFITM proteins are important cofactors for SARS-CoV-2 infection of human cell types representing in vivo targets for viral transmission, dissemination and pathogenesis and suitable targets for therapeutic approaches.